NO962811L - Nye heterosykliske forbindelser - Google Patents

Nye heterosykliske forbindelser

Info

Publication number: NO962811L
Authority: NO; Norway
Prior art keywords: heterocyclic compounds; new heterocyclic; substituted; hyperalgesic; painful
Prior art date: 1994-01-04

Application number

NO962811A

Other languages

English (en)

Other versions

NO306295B1 (no

NO962811D0 (no

Inventor

Knud Erik Andersen

Uffe Bang Olsen

Hans Petersen

Ursula Sonnewald

Tine Krogh Joergensen

Henrik Sune Andersen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-04

Filing date

1996-07-03

Publication date

1996-09-04

1996-07-03 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1996-07-03 Publication of NO962811D0 publication Critical patent/NO962811D0/no

1996-09-04 Publication of NO962811L publication Critical patent/NO962811L/no

1999-10-18 Publication of NO306295B1 publication Critical patent/NO306295B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Indole Compounds (AREA)

NO962811A 1994-01-04 1996-07-03 Heterosykliske forbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter NO306295B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK1994		1994-01-04
DK129094		1994-11-09
PCT/DK1995/000002 WO1995018793A1 (en)	1994-01-04	1995-01-03	Novel heterocyclic compounds

Publications (3)

Publication Number	Publication Date
NO962811D0 NO962811D0 (no)	1996-07-03
NO962811L true NO962811L (no)	1996-09-04
NO306295B1 NO306295B1 (no)	1999-10-18

Family

ID=26063135

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO962811A NO306295B1 (no)	1994-01-04	1996-07-03	Heterosykliske forbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter

Country Status (31)

Country	Link
US (8)	US5595989A (no)
EP (1)	EP0738262B1 (no)
JP (1)	JP2944221B2 (no)
KR (1)	KR100329450B1 (no)
CN (1)	CN1083431C (no)
AT (1)	ATE191909T1 (no)
AU (1)	AU691858B2 (no)
BG (1)	BG100692A (no)
BR (1)	BR9506452A (no)
CA (1)	CA2180238A1 (no)
CZ (1)	CZ286109B6 (no)
DE (1)	DE69516394T2 (no)
DK (1)	DK0738262T3 (no)
ES (1)	ES2147837T3 (no)
FI (1)	FI114025B (no)
GR (1)	GR3033967T3 (no)
HU (1)	HUT75878A (no)
IL (1)	IL112222A (no)
MY (1)	MY113463A (no)
NO (1)	NO306295B1 (no)
NZ (1)	NZ277763A (no)
PE (1)	PE45095A1 (no)
PL (1)	PL180209B1 (no)
PT (1)	PT738262E (no)
RU (1)	RU2167152C2 (no)
SG (1)	SG50602A1 (no)
SI (1)	SI9520023A (no)
SK (1)	SK88196A3 (no)
TW (1)	TW300887B (no)
UA (1)	UA47396C2 (no)
WO (1)	WO1995018793A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6110913A (en) *	1994-01-04	2000-08-29	Novo Nordisk A/S	N-substituted azaheterocyclic carboxylic acids and esters thereof
MY113463A (en) *	1994-01-04	2002-03-30	Novo Nordisk As	Novel heterocyclic compounds
US6239148B1 (en)	1994-01-04	2001-05-29	Novo Nordisk A/S	N-substituted azaheterocyclic carboxylic acids and esters thereof
US5716949A (en) *	1995-04-07	1998-02-10	Novo Nordisk A/S	Heterocyclic compounds
US5698551A (en) *	1995-04-07	1997-12-16	Novo Nordisk A/S	Heterocyclic compounds
UA54385C2 (uk) *	1995-04-07	2003-03-17	Ново Нордіск А/С	N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
US5962449A (en)	1995-04-07	1999-10-05	Novo Nordisk A/S	Tricyclic compounds in treating hyperalgesic conditions and NIDDM
US5952352A (en) *	1995-04-07	1999-09-14	Novo Nordisk A/S	Heterocyclic compounds
PL327445A1 (en) *	1995-12-15	1998-12-07	Novo Nordisk As	Novel process
US6323206B1 (en)	1996-07-12	2001-11-27	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
ZA978792B (en) *	1996-10-04	1998-04-06	Novo Nordisk As	N-substituted azaheterocyclic compounds.
WO1998015548A1 (en) *	1996-10-04	1998-04-16	Novo Nordisk A/S	1,4-disubstituted piperazines
CA2267500A1 (en) *	1996-10-04	1998-04-16	Novo Nordisk A/S	N-substituted azaheterocyclic compounds
US6040318A (en) *	1997-06-25	2000-03-21	Novo Nordisk A/S	Tricycle substituted with azaheterocyclic carboxylic acids
CA2307820C (en)	1997-10-27	2007-04-24	Dr. Reddy's Research Foundation	Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
US6613905B1 (en)	1998-01-21	2003-09-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
CA2318088A1 (en) *	1998-01-21	1999-07-29	Yoshisuke Nakasato	Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en)	1998-01-21	2003-01-21	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
HUP0101320A3 (en)	1998-01-21	2002-11-28	Kyowa Hakko Kogyo Kk	Benzo- and pyridobenzoxepine and -benzazepine derivatives and use thereof
ES2137136B1 (es) *	1998-05-18	2000-07-01	Esteve Labor Dr	Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
US7271176B2 (en) *	1998-09-04	2007-09-18	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
US6468996B1 (en) *	1998-10-21	2002-10-22	Novo Nordisk A/S	Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
US6207682B1 (en)	1998-12-22	2001-03-27	Novo Nordisk A/S	Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-piperidinecarboxylic acid
JP2002532551A (ja) *	1998-12-22	2002-10-02	ノボノルディスクアクティーゼルスカブ	新規製剤
US7355042B2 (en) *	2001-10-16	2008-04-08	Hypnion, Inc.	Treatment of CNS disorders using CNS target modulators
US7541365B2 (en) *	2001-11-21	2009-06-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US20040087642A1 (en) *	2002-10-24	2004-05-06	Zeldis Jerome B.	Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
TWI291467B (en) *	2002-11-13	2007-12-21	Millennium Pharm Inc	CCR1 antagonists and methods of use therefor
WO2004112705A2 (en) *	2003-06-16	2004-12-29	Hypnion, Inc.	Methods for treating sleep disorders
CA2662215A1 (en)	2006-09-01	2008-03-06	Immune Control, Inc.	Novel compositions and methods for treatment of diseases related to activated lymphocytes
WO2017040963A1 (en)	2015-09-03	2017-03-09	Forma Therapeutics, Inc.	[6,6] fused bicyclic hdac8 inhibitors
JP2020526592A (ja)	2017-07-13	2020-08-31	トニックスファーマシューティカルズホールディングコーポレーション	シクロベンザプリン類似体及びアミトリプチレン類似体
CN115850232B (zh) *	2023-02-16	2023-05-26	广州佳途科技股份有限公司	一种氟哌噻吨ep杂质h的制备方法及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3316249A (en) *		1967-04-25		Part a.xmethyl n n-(z-diethylaminoethyl)-n-(z- nitrophenyl) anthranilate hydrochloride
US2931810A (en) *		1960-04-05		Phenothiazine derivatives
BE552557A (no) *	1955-11-15
NL108827C (no) *	1956-04-09
BE562299A (no) *	1956-11-15
BE560750A (no) *	1957-07-26
NL222355A (no) *	1957-11-05
FR1216268A (fr) *	1958-04-24	1960-04-25	Rhone Poulenc Sa	Nouveaux dérivés de la phénothiazine à chaîne pipéridine substituée par une fonction amide et leur préparation
US3069432A (en) *	1961-02-20	1962-12-18	Olin Mathieson	5-(aminoalkyl)-5, 11-dihydrodibenzo-oxazepines
DE1159954B (de) *	1961-11-25	1963-12-27	Boehringer & Soehne Gmbh	Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
US3157658A (en) *	1963-07-05	1964-11-17	Searle & Co	1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
BE664609A (no) *	1964-06-01
US3886170A (en) *	1974-04-22	1975-05-27	Robins Co Inc A H	5-(3-)SUBSTITUTED-10,11-DIHYDRO-5H-dibenz{8 b,f{9 azepines
US4888335A (en) *	1988-07-25	1989-12-19	Mcneilab, Inc.	3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
US5296602A (en) *	1991-03-18	1994-03-22	Sloan-Kettering Institute For Cancer Research	Multisubstituted 1-hydroxy-9-acridones with anticancer activity
US5420123A (en) *	1992-12-21	1995-05-30	Bristol-Myers Squibb Company	Dibenzodiazepine endothelin antagonists
US5538986A (en) *	1993-12-06	1996-07-23	Schering Corporation	Tricyclic derivatives, compositions and methods of use
MY113463A (en) *	1994-01-04	2002-03-30	Novo Nordisk As	Novel heterocyclic compounds

1994
- 1994-12-30 MY MYPI94003583A patent/MY113463A/en unknown
1995
- 1995-01-02 IL IL11222295A patent/IL112222A/xx not_active IP Right Cessation
- 1995-01-03 SG SG1996006195A patent/SG50602A1/en unknown
- 1995-01-03 EP EP95904409A patent/EP0738262B1/en not_active Expired - Lifetime
- 1995-01-03 UA UA96072659A patent/UA47396C2/uk unknown
- 1995-01-03 ES ES95904409T patent/ES2147837T3/es not_active Expired - Lifetime
- 1995-01-03 AU AU13110/95A patent/AU691858B2/en not_active Ceased
- 1995-01-03 RU RU96116134/04A patent/RU2167152C2/ru not_active IP Right Cessation
- 1995-01-03 DE DE69516394T patent/DE69516394T2/de not_active Expired - Fee Related
- 1995-01-03 SI SI9520023A patent/SI9520023A/sl unknown
- 1995-01-03 CZ CZ19961921A patent/CZ286109B6/cs unknown
- 1995-01-03 PL PL95315294A patent/PL180209B1/pl not_active IP Right Cessation
- 1995-01-03 JP JP7518275A patent/JP2944221B2/ja not_active Expired - Fee Related
- 1995-01-03 PT PT95904409T patent/PT738262E/pt unknown
- 1995-01-03 BR BR9506452A patent/BR9506452A/pt not_active IP Right Cessation
- 1995-01-03 KR KR1019960703605A patent/KR100329450B1/ko not_active Expired - Fee Related
- 1995-01-03 US US08/367,648 patent/US5595989A/en not_active Expired - Fee Related
- 1995-01-03 DK DK95904409T patent/DK0738262T3/da active
- 1995-01-03 CN CN95191845A patent/CN1083431C/zh not_active Expired - Fee Related
- 1995-01-03 AT AT95904409T patent/ATE191909T1/de not_active IP Right Cessation
- 1995-01-03 HU HU9601842A patent/HUT75878A/hu unknown
- 1995-01-03 NZ NZ277763A patent/NZ277763A/en unknown
- 1995-01-03 SK SK881-96A patent/SK88196A3/sk unknown
- 1995-01-03 CA CA002180238A patent/CA2180238A1/en not_active Abandoned
- 1995-01-03 WO PCT/DK1995/000002 patent/WO1995018793A1/en not_active Ceased
- 1995-01-04 PE PE1995258527A patent/PE45095A1/es not_active Application Discontinuation
- 1995-02-22 TW TW084101613A patent/TW300887B/zh active
- 1995-05-18 US US08/444,140 patent/US5688788A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,682 patent/US5795888A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,500 patent/US5721254A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,905 patent/US5712292A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,502 patent/US5693649A/en not_active Expired - Fee Related
1996
- 1996-03-27 US US08/626,745 patent/US5668129A/en not_active Expired - Fee Related
- 1996-07-02 BG BG100692A patent/BG100692A/xx unknown
- 1996-07-03 NO NO962811A patent/NO306295B1/no not_active IP Right Cessation
- 1996-07-04 FI FI962749A patent/FI114025B/fi active
1998
- 1998-01-23 US US09/012,918 patent/US6043239A/en not_active Expired - Fee Related
2000
- 2000-07-17 GR GR20000401652T patent/GR3033967T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL112222A (en)	1999-12-31
BG100692A (en)	1997-09-30
US5688788A (en)	1997-11-18
US5693649A (en)	1997-12-02
FI962749L (fi)	1996-09-04
FI962749A0 (fi)	1996-07-04
WO1995018793A1 (en)	1995-07-13
US5595989A (en)	1997-01-21
HUT75878A (en)	1997-05-28
US5712292A (en)	1998-01-27
DK0738262T3 (da)	2000-09-04
SI9520023A (en)	1997-04-30
AU691858B2 (en)	1998-05-28
US5668129A (en)	1997-09-16
TW300887B (no)	1997-03-21
US6043239A (en)	2000-03-28
SG50602A1 (en)	1998-07-20
JPH09507239A (ja)	1997-07-22
EP0738262A1 (en)	1996-10-23
NO306295B1 (no)	1999-10-18
CN1083431C (zh)	2002-04-24
GR3033967T3 (en)	2000-11-30
RU2167152C2 (ru)	2001-05-20
JP2944221B2 (ja)	1999-08-30
HU9601842D0 (en)	1996-09-30
NZ277763A (en)	2001-11-30
CN1142226A (zh)	1997-02-05
FI114025B (fi)	2004-07-30
CA2180238A1 (en)	1995-07-13
AU1311095A (en)	1995-08-01
PL180209B1 (pl)	2001-01-31
US5795888A (en)	1998-08-18
EP0738262B1 (en)	2000-04-19
CZ286109B6 (cs)	2000-01-12
ES2147837T3 (es)	2000-10-01
US5721254A (en)	1998-02-24
BR9506452A (pt)	1997-09-02
IL112222A0 (en)	1995-03-30
KR100329450B1 (ko)	2002-10-04
PE45095A1 (es)	1995-12-18
UA47396C2 (uk)	2002-07-15
DE69516394T2 (de)	2000-10-26
NO962811D0 (no)	1996-07-03
SK88196A3 (en)	1997-06-04
PT738262E (pt)	2000-10-31
DE69516394D1 (de)	2000-05-25
CZ192196A3 (en)	1997-05-14
MY113463A (en)	2002-03-30
ATE191909T1 (de)	2000-05-15

Publication	Publication Date	Title
NO962811D0 (no)	1996-07-03	Nye heterosykliske forbindelser
MX9707531A (es)	1997-11-29	Nuevos compuestos heterociclicos.
EA200100971A1 (ru)	2002-02-28	Новые соединения и композиции в качестве ингибиторов протеазы
EA200201271A1 (ru)	2003-04-24	Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
PE59099A1 (es)	1999-06-21	Nuevos derivados del acido hexanoico
AR048080A2 (es)	2006-03-29	Metodo para el control de enfermedades y horticolas de plantas
PE52799A1 (es)	1999-05-27	Cicloalquilo, lactama, lactona y compuestos relacionados, composiciones farmaceuticas que comprenden los mismos, como inhibidores de la liberacion de peptido �-amiloide y no cicloalquilo, lactama, lactona y compuestos relacionados, como inhibidores de la liberacion del peptido �-amiloide
AR031809A1 (es)	2003-10-01	Quinolonas antimicrobianas, sus composiciones y usos
BR0108816A (pt)	2002-12-10	Derivados de quinolina como antagonistas alfa-2
EA200101077A1 (ru)	2002-04-25	Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его
BR9713178A (pt)	2000-02-08	Inbidores espirocìclicos da metaloprotease.
DE69615169D1 (de)	2001-10-18	N-substituierte azaheterocyclische Carbonsäuren und ihre Alkylester
DK0669912T3 (da)	2002-03-04	N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
DE3763863D1 (de)	1990-08-30	Substituierte tetrahydro-3-pyridincarbonsaeuren, ihre ester und amide als cholinergische mittel.
BR0109328A (pt)	2003-06-10	Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
NO965097L (no)	1997-01-31	Nye elastaseinhibitorer
AU5100496A (en)	1996-10-23	Novel heterocyclic compounds
AR043186A1 (es)	2005-07-20	Indozolamidas dotadas de actividad analgesica, metodo de preparacion de las mismas y compuesto farmaceutico que las comprende
NO955263L (no)	1996-02-22	N-substituerte azaheterosykliske karboksylsyrer og estere derav
IL117812A0 (en)	1996-08-04	N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
NO955112L (no)	1995-12-15	Fremgangsmåte for fremstilling av oksazolidinkarboksylsyre samt anvendelse derav for fremstiling av terapeutisk aktive taxoider
ATE293591T1 (de)	2005-05-15	Neue n-(2-phenyl-3-aminopropyl)naphtamide
UY28618A1 (es)	2005-06-30	Nuevos indoles sustituidos de piperidina o heteroderivados de los mismos
ATE278403T1 (de)	2004-10-15	Verfahren zur inhibierung von katarakten
ATE233244T1 (de)	2003-03-15	Carboxylsäure substituierte heterocyclische verbindungen als metalloproteinase inhibitoren

Legal Events

Date	Code	Title	Description
2004-12-13	MM1K	Lapsed by not paying the annual fees